№ lp_1_2_22593
File format: docx
Character count: 7516
File size: 63 KB
This document provides guidance for covered entities requesting approval to establish a combined purchasing and distribution model under the 340B Drug Pricing Program.
Year:
2021
Region / City:
Rockville, MD
Topic:
340B Drug Pricing Program
Document Type:
Guidance
Organization / Institution:
Health Resources and Services Administration (HRSA)
Author:
Apexus
Target Audience:
340B stakeholders, covered entities, health departments
Effective Period:
Ongoing
Approval Date:
2021
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
United States
Topic:
Medicaid, 340B Program
Document Type:
Instructional Form
Organization:
HRSA (Health Resources and Services Administration)
Author:
HRSA
Target Audience:
Covered entities, contract pharmacies, Medicaid providers
Effective Period:
Ongoing
Approval Date:
March 5, 2010
Modification Date:
December 12, 2014
Year:
2025
Region / City:
United States
Topic:
340B Program Financial Impact
Document Type:
Tool / Guide
Organization / Institution:
Apexus
Author:
Apexus
Target Audience:
340B Covered Entities, Medicaid Agencies
Period of Validity:
2025
Approval Date:
2025
Modification Date:
Not specified
Year:
2024
Region / City:
United States
Subject:
340B Contract Pharmacy Policy Changes
Document Type:
Internal Memo
Organization:
Bausch Health
Author:
Bausch Health
Target Audience:
Internal employees of Bausch Health
Effective Date:
June 6, 2024
Amendment Date:
June 20, 2024
Start Date of Policy Change:
June 6, 2024
End Date of Policy Change:
October 1, 2025
Background:
In 1996, HHS issued guidance on 340B contract pharmacies.
Context:
This document provides detailed updates on Bausch Health’s evolving 340B contract pharmacy policies.
Year:
2025
Region / City:
Not specified
Topic:
340B Compliance Audit
Document Type:
Instructional Guide
Organization / Institution:
Apexus LLC
Author:
Not specified
Target Audience:
Covered Entity Leaders
Period of Action:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / City:
United States
Theme:
Healthcare, Pharmaceutical Purchasing
Document Type:
Guidelines
Organization:
340B Program
Author:
Not specified
Target Audience:
Covered entities in 340B hospitals
Validity Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Theme:
Pharmaceutical industry
Document type:
Manufacturer communication
Organization / institution:
[Manufacturer]
Author:
[Manufacturer]
Target audience:
Covered entities, stakeholders in the 340B program
Year:
2024
Program:
340B Drug Pricing Program
Subject:
Compliance policy and self-disclosure procedures
Document Type:
Guidance framework
Issuing Organization:
Apexus
Related Authority:
Health Resources and Services Administration (HRSA)
Intended Audience:
340B covered entity leaders and stakeholders
Scope:
Definition of material breach and self-disclosure to HRSA and manufacturers
Key Components:
Threshold indicators, policy criteria, sample statement, review procedures
Compliance Focus:
Diversion and duplicate discounts
Copyright:
© 2024 Apexus
Usage Rights:
Permitted for use, copying, and distribution by 340B covered entities and Medicaid agencies
Year:
2023
Region / City:
United States
Topic:
340B Program, Children’s Hospitals, Healthcare
Document Type:
Registration Form
Organization / Institution:
Office of Pharmacy Affairs (OPA)
Author:
Not specified
Target Audience:
Healthcare Providers, Children’s Hospitals
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2021
Date:
20 August 2021
Version:
1.0
Document type:
User guide
Industry:
Aerospace industry
Topic:
Scope 3 greenhouse gas emissions
GHG scope:
Scope 3
Emission categories:
Purchased Goods & Services; Capital Goods
Methodological basis:
GHG Protocol Corporate Value Chain (Scope 3) Accounting and Reporting Standard
Organization:
International Aerospace Environmental Group (IAEG)
Working group:
IAEG Work Group 3
Purpose:
Voluntary accounting and reporting of greenhouse gas emissions
Geographical scope:
Aerospace industry value chain
Copyright holder:
International Aerospace Environmental Group (IAEG)
Status:
Informational document, not a standard
Approval date:
20 August 2021
Intended users:
Aerospace and defense companies and value chain partners
Period covered:
Not specified
Note:
Year
Subject:
Water System Review and Permitting
Document Type:
Checklist
Year:
2023
Region / City:
USA
Topic:
Cybersecurity Services, Risk Assessment, Vulnerability Testing
Document Type:
Template
Agency/Institution:
HACS
Author:
HACS
Target Audience:
Federal Agencies, Contractors
Period of Action:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2015
Region / City:
Czech Republic
Topic:
Reliability, Availability, Maintainability (RAM), Life Cycle Cost (LCC)
Document Type:
Instruction
Organization / Institution:
ŠKODA ELECTRIC a.s.
Author:
ŠKODA ELECTRIC a.s.
Target Audience:
Suppliers, Manufacturers
Validity Period:
Not specified
Approval Date:
14.11.2019
Revision Date:
14.11.2019
Change Description:
Updated address of ŠKODA ELECTRIC, minor changes in Chapter 4.1, added title in Chapter 4.2
Year:
2018
Region / City:
Tucson, AZ
Theme:
Food Safety, Product Recall
Document Type:
Recall Notice
Period of validity:
May 24, 2018
Date of approval:
May 25, 2018
Date of changes:
None
Context:
Recall notice issued for refrigerated products sold at a Fry’s Food Store due to temperature-related issues causing potential spoilage.
Note:
Year
Subject:
Veterinary medicine record
Document Type:
Record sheet
Context description:
A record sheet for documenting the purchase details of veterinary medicines.
Year:
2026
Region:
United States
Topic:
Healthcare Claims Management
Document Type:
Guideline
Agency:
Veterans Affairs
Author:
Program Integrity Department
Target Audience:
Medical providers, healthcare facilities
Legal Reference:
31 U.S.C. 3729
Claim Types:
Purchased Care, CHAMPVA
Period of Application:
Ongoing
Date of Issue:
2026
Revision Date:
N/A
Content Focus:
Pre-payment claim scoring, rejection codes, overpayment recovery procedures
Year:
2024
Country:
South Africa
Institution:
National Assembly
Document type:
Parliamentary question and written reply
Question number:
597
Internal question paper number:
08
Publication date:
08 March 2024
Author of question:
Mr J N de Villiers (DA)
Responding authority:
Minister of Health
Government department:
Department of Health
Subject:
Government vehicle procurement for executive authorities
Reference question:
Question 86 replied to on 22 February 2023
Period covered:
8 May 2019 – 08 March 2024
Officials mentioned:
Dr MJ Phaahla, Dr ZL Mkhize, Dr S Dhlomo
Vehicle recorded:
Audi Q5 (2020)
Vehicle purchase date:
10 May 2020
Vehicle purchase price:
R 756,489.83
Type:
Evaluation form
Subject:
Textile and clothing assessment
Category fields:
Category number; Category name
Participant information:
Name (Last, First, Middle)
Affiliation:
Club/School
Award levels:
Blue; Red; White; No Award
Display compliance:
Displayed according to rules (Yes/No)
Evaluation criteria:
Selection and general appearance; Workmanship
Assessment items:
Overall appearance; Neat and clean; Pattern/fabric coordination; Color coordination; Article appropriate for intended use; Glues/adhesives are not visible; Trims/decorations properly attached; Decorations are appropriate and neat; Threads clipped
Scoring options:
Blue; Red; White; Needs Improvement
Additional notes:
Comments section included
Note:
Year
Type of Disinfectant:
Free chlorine / Chloramine
Minimum Residual:
0.2 mg/L for free chlorine, 0.5 mg/L for chloramine
Number of Customers:
Fewer than 750
Sampling Frequency:
Weekly for distribution system, monthly with coliform samples
Sample Count:
Up to 5 per worksheet
Data Recorded:
Sample date, sample site, disinfectant residual, below minimum, no residual
Reporting Form:
DLQOR
Purpose:
Monitoring disinfectant levels in small water systems
Year:
1997
Region / City:
United States
Topic:
Inpatient medication management
Document Type:
Manual
Organization / Institution:
Department of Veterans Affairs
Author:
Not specified
Target Audience:
Healthcare professionals in the Veterans Affairs system
Effective Period:
Ongoing updates
Approval Date:
December 1997
Revision Date:
August 2025